CSTL FY 2025 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$805M

FY 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$344M+3.7% YoY

Gross Profit

$236M68.7% margin

Operating Income

-$43M-12.4% margin

Net Income

-$24M-7.0% margin

EPS (Diluted)

$-0.83

Cash Flow

Operating Cash Flow

$64M

Free Cash Flow

$28M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$579M

Total Liabilities

$108M

Stockholders' Equity

$471M

Cash & Equivalents

$117M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$344M	$332M	+3.7%
Gross Profit	$236M	$272M	-13.1%
Operating Income	-$43M	$9M	-593.8%
Net Income	-$24M	$18M	-232.4%